Tasca Therapeutics, the first startup created by new VC firm Cure Ventures, has raised $52 million to develop a new breed of cancer therapies. Tasca
What happens when two computer scientists and a former stem cell researcher become friends while working their way up the venture capital corporate ladder and
Atlas Venture, one of the leading venture capital firms in the biotech industry, has raised $450 million for a new fund, the firm’s leaders told
Radiation is a core part of cancer treatment, and has been for generations. But over the last couple of years, there’s been a surge of
Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug development, laid off employees after closing a
Biotech startup Orna Therapeutics has cut more jobs in its second round of layoffs in the last year, STAT has learned. Orna was part of
Axonis Therapeutics, a biotech company that has been quietly operating for the last five years, has raised $115 million after retooling its drug pipeline. The
Seaport Therapeutics, the startup launched earlier this year by the team behind Karuna Therapeutics, has raised another $225 million just six months after its most
Veteran biotech executive Tony Coles has been the man behind the curtain of two multibillion-dollar acquisitions and many more boardroom discussions. But, publicly, he has
Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. But there’s one field that has